Community-based opioid overdose prevention programs providing naloxone - United States, 2010
- PMID: 22337174
- PMCID: PMC4378715
Community-based opioid overdose prevention programs providing naloxone - United States, 2010
Abstract
Drug overdose death rates have increased steadily in the United States since 1979. In 2008, a total of 36,450 drug overdose deaths (i.e., unintentional, intentional [suicide or homicide], or undetermined intent) were reported, with prescription opioid analgesics (e.g., oxycodone, hydrocodone, and methadone), cocaine, and heroin the drugs most commonly involved . Since the mid-1990s, community-based programs have offered opioid overdose prevention services to persons who use drugs, their families and friends, and service providers. Since 1996, an increasing number of these programs have provided the opioid antagonist naloxone hydrochloride, the treatment of choice to reverse the potentially fatal respiratory depression caused by overdose of heroin and other opioids. Naloxone has no effect on non-opioid overdoses (e.g., cocaine, benzodiazepines, or alcohol) . In October 2010, the Harm Reduction Coalition, a national advocacy and capacity-building organization, surveyed 50 programs known to distribute naloxone in the United States, to collect data on local program locations, naloxone distribution, and overdose reversals. This report summarizes the findings for the 48 programs that completed the survey and the 188 local programs represented by the responses. Since the first opioid overdose prevention program began distributing naloxone in 1996, the respondent programs reported training and distributing naloxone to 53,032 persons and receiving reports of 10,171 overdose reversals. Providing opioid overdose education and naloxone to persons who use drugs and to persons who might be present at an opioid overdose can help reduce opioid overdose mortality, a rapidly growing public health concern.
Figures
Similar articles
-
Opioid Overdose Prevention Programs Providing Naloxone to Laypersons - United States, 2014.MMWR Morb Mortal Wkly Rep. 2015 Jun 19;64(23):631-5. MMWR Morb Mortal Wkly Rep. 2015. PMID: 26086633 Free PMC article.
-
Opioid education and nasal naloxone rescue kits in the emergency department.West J Emerg Med. 2015 May;16(3):381-4. doi: 10.5811/westjem.2015.2.24909. Epub 2015 Apr 1. West J Emerg Med. 2015. PMID: 25987910 Free PMC article.
-
HIV prevention and treatment strategies can help address the overdose crisis.Prev Med. 2015 Nov;80:37-40. doi: 10.1016/j.ypmed.2015.04.004. Epub 2015 Apr 18. Prev Med. 2015. PMID: 25895840
-
A systematic review of community opioid overdose prevention and naloxone distribution programs.J Addict Med. 2014 May-Jun;8(3):153-63. doi: 10.1097/ADM.0000000000000034. J Addict Med. 2014. PMID: 24874759 Review.
-
A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.Subst Abus. 2015;36(2):240-53. doi: 10.1080/08897077.2015.1010032. Epub 2015 Mar 16. Subst Abus. 2015. PMID: 25774771 Free PMC article. Review.
Cited by
-
Effectiveness of direct patient outreach with a narrative naloxone and overdose prevention video to patients prescribed long-term opioid therapy in the USA: the Naloxone Navigator randomised clinical trial.BMJ Public Health. 2024 Jul;2(1):e000725. doi: 10.1136/bmjph-2023-000725. Epub 2024 Jul 8. BMJ Public Health. 2024. PMID: 39421268 Free PMC article.
-
Bystanders Saving Lives with Naloxone: A Scoping Review on Methods to Estimate Overdose Reversals.West J Emerg Med. 2024 Jul;25(4):500-506. doi: 10.5811/westjem.18037. West J Emerg Med. 2024. PMID: 39028236 Free PMC article. Review.
-
Neighborhood and Individual Disparities in Community-Based Naloxone Access for Opioid Overdose Prevention.J Urban Health. 2024 Feb;101(1):64-74. doi: 10.1007/s11524-023-00821-z. Epub 2024 Jan 9. J Urban Health. 2024. PMID: 38196059
-
Implementing a decentralized opioid overdose prevention strategy in Mexico, a pending public policy issue.Lancet Reg Health Am. 2023 Jun 17;23:100535. doi: 10.1016/j.lana.2023.100535. eCollection 2023 Jul. Lancet Reg Health Am. 2023. PMID: 37351156 Free PMC article. Review.
-
Influences on advance practice nursing education to prescribe medications for opioid use disorder.Nurs Outlook. 2023 May-Jun;71(3):101963. doi: 10.1016/j.outlook.2023.101963. Epub 2023 Mar 30. Nurs Outlook. 2023. PMID: 37003088 Free PMC article.
References
-
- CDC. WONDER [Database] Atlanta, GA: US Department of Health and Human Services, CDC; 2012. [Accessed February 13, 2012]. Available at http://wonder.cdc.gov.
-
- Hardman JG, Limbird LE, editors. Goodman and Gilman’s the pharmacologic basis of therapeutics. 11. New York, NY: McGraw-Hill; 2006. pp. 576–8.
-
- Wermeling DP. Opioid harm reduction strategies: focus on expanded access to intranasal naloxone [Editorial] Pharmacotherapy. 2010;30:627–31. - PubMed
-
- Lagu T, Anderson BJ, Stein M. Overdoses among friends: drug users are willing to administer naloxone to others. J Subst Abuse Treat. 2006;30:129–33. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical

